MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients

Adrian P. Trifa, Claudia Bănescu, Anca S. Bojan, Cristian M. Voina, Ștefana Popa, Simona Vișan, Alina D. Ciubean, Florin Tripon, Delia Dima, Viola M. Popov, Ștefan C. Vesa, Mihaela Andreescu, Tünde Török-Vistai, Romeo G. Mihăilă, Nicoleta Berbec, Ioan Macarie, Andrei Coliţă, Maria Iordache, Alina C. Cătană, Marius F. FarcașCiprian Tomuleasa, Kinga Vasile, Cristina Truică, Adriana Todincă, Lavinia Pop-Muntean, Raluca Manolache, Horia Bumbea, Ana Maria Vlădăreanu, Mihaela Gaman, Cristina M. Ciufu, Radu A. Popp

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical myeloproliferative neoplasms (MPN), characterized by specific somatic mutations in JAK2, CALR or MPL genes. JAK2 46/1 and TERT rs2736100 polymorphisms are known to significantly predispose to MPN. This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN. These three polymorphisms, along with JAK2 46/1 and TERT rs2736100 were genotyped in 939 MPN patients (454 with ET, 337 with PV and 148 with PMF) and 483 controls. MECOM rs2201862 associated significantly with each MPN entity, except for ET, and with all major molecular sub-types, especially those CALR-mutated (OR = 1.4; 95% CI = 1.1-1.8; P-value =.005). HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95% CI = 1.1-1.7; P-value =.003). THRB-RARB rs4858647 had a weak association with PMF only (OR = 1.5; 95% CI = 1-2.1; P-value =.04). Surprisingly, JAK2 46/1 haplotype was associated significantly not only with JAK2 V617F-mutated MPN, but also with CALR-mutated MPN (OR = 1.4; 95% CI = 1.1-1.8; P-value =.01). TERT rs2736100 was associated equally strong with all MPN, regardless of phenotype or molecular sub-type. In conclusion, JAK2 46/1, TERT rs2736100 and MECOM rs2201862 are the chief predisposing polymorphisms to MPN.

Original languageEnglish (US)
Pages (from-to)100-106
Number of pages7
JournalAmerican Journal of Hematology
Volume93
Issue number1
DOIs
StatePublished - Jan 2018

Fingerprint

Genetic Predisposition to Disease
Essential Thrombocythemia
Neoplasms
Primary Myelofibrosis
Polycythemia Vera
Haplotypes
Phenotype
Mutation

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Trifa, Adrian P. ; Bănescu, Claudia ; Bojan, Anca S. ; Voina, Cristian M. ; Popa, Ștefana ; Vișan, Simona ; Ciubean, Alina D. ; Tripon, Florin ; Dima, Delia ; Popov, Viola M. ; Vesa, Ștefan C. ; Andreescu, Mihaela ; Török-Vistai, Tünde ; Mihăilă, Romeo G. ; Berbec, Nicoleta ; Macarie, Ioan ; Coliţă, Andrei ; Iordache, Maria ; Cătană, Alina C. ; Farcaș, Marius F. ; Tomuleasa, Ciprian ; Vasile, Kinga ; Truică, Cristina ; Todincă, Adriana ; Pop-Muntean, Lavinia ; Manolache, Raluca ; Bumbea, Horia ; Vlădăreanu, Ana Maria ; Gaman, Mihaela ; Ciufu, Cristina M. ; Popp, Radu A. / MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms : A study on 939 patients. In: American Journal of Hematology. 2018 ; Vol. 93, No. 1. pp. 100-106.
@article{0762faa881ed49059583bc86b40af115,
title = "MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients",
abstract = "Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical myeloproliferative neoplasms (MPN), characterized by specific somatic mutations in JAK2, CALR or MPL genes. JAK2 46/1 and TERT rs2736100 polymorphisms are known to significantly predispose to MPN. This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN. These three polymorphisms, along with JAK2 46/1 and TERT rs2736100 were genotyped in 939 MPN patients (454 with ET, 337 with PV and 148 with PMF) and 483 controls. MECOM rs2201862 associated significantly with each MPN entity, except for ET, and with all major molecular sub-types, especially those CALR-mutated (OR = 1.4; 95{\%} CI = 1.1-1.8; P-value =.005). HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95{\%} CI = 1.1-1.7; P-value =.003). THRB-RARB rs4858647 had a weak association with PMF only (OR = 1.5; 95{\%} CI = 1-2.1; P-value =.04). Surprisingly, JAK2 46/1 haplotype was associated significantly not only with JAK2 V617F-mutated MPN, but also with CALR-mutated MPN (OR = 1.4; 95{\%} CI = 1.1-1.8; P-value =.01). TERT rs2736100 was associated equally strong with all MPN, regardless of phenotype or molecular sub-type. In conclusion, JAK2 46/1, TERT rs2736100 and MECOM rs2201862 are the chief predisposing polymorphisms to MPN.",
author = "Trifa, {Adrian P.} and Claudia Bănescu and Bojan, {Anca S.} and Voina, {Cristian M.} and Ștefana Popa and Simona Vișan and Ciubean, {Alina D.} and Florin Tripon and Delia Dima and Popov, {Viola M.} and Vesa, {Ștefan C.} and Mihaela Andreescu and T{\"u}nde T{\"o}r{\"o}k-Vistai and Mihăilă, {Romeo G.} and Nicoleta Berbec and Ioan Macarie and Andrei Coliţă and Maria Iordache and Cătană, {Alina C.} and Farcaș, {Marius F.} and Ciprian Tomuleasa and Kinga Vasile and Cristina Truică and Adriana Todincă and Lavinia Pop-Muntean and Raluca Manolache and Horia Bumbea and Vlădăreanu, {Ana Maria} and Mihaela Gaman and Ciufu, {Cristina M.} and Popp, {Radu A.}",
year = "2018",
month = "1",
doi = "10.1002/ajh.24946",
language = "English (US)",
volume = "93",
pages = "100--106",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Trifa, AP, Bănescu, C, Bojan, AS, Voina, CM, Popa, Ș, Vișan, S, Ciubean, AD, Tripon, F, Dima, D, Popov, VM, Vesa, ȘC, Andreescu, M, Török-Vistai, T, Mihăilă, RG, Berbec, N, Macarie, I, Coliţă, A, Iordache, M, Cătană, AC, Farcaș, MF, Tomuleasa, C, Vasile, K, Truică, C, Todincă, A, Pop-Muntean, L, Manolache, R, Bumbea, H, Vlădăreanu, AM, Gaman, M, Ciufu, CM & Popp, RA 2018, 'MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients', American Journal of Hematology, vol. 93, no. 1, pp. 100-106. https://doi.org/10.1002/ajh.24946

MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms : A study on 939 patients. / Trifa, Adrian P.; Bănescu, Claudia; Bojan, Anca S.; Voina, Cristian M.; Popa, Ștefana; Vișan, Simona; Ciubean, Alina D.; Tripon, Florin; Dima, Delia; Popov, Viola M.; Vesa, Ștefan C.; Andreescu, Mihaela; Török-Vistai, Tünde; Mihăilă, Romeo G.; Berbec, Nicoleta; Macarie, Ioan; Coliţă, Andrei; Iordache, Maria; Cătană, Alina C.; Farcaș, Marius F.; Tomuleasa, Ciprian; Vasile, Kinga; Truică, Cristina; Todincă, Adriana; Pop-Muntean, Lavinia; Manolache, Raluca; Bumbea, Horia; Vlădăreanu, Ana Maria; Gaman, Mihaela; Ciufu, Cristina M.; Popp, Radu A.

In: American Journal of Hematology, Vol. 93, No. 1, 01.2018, p. 100-106.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms

T2 - A study on 939 patients

AU - Trifa, Adrian P.

AU - Bănescu, Claudia

AU - Bojan, Anca S.

AU - Voina, Cristian M.

AU - Popa, Ștefana

AU - Vișan, Simona

AU - Ciubean, Alina D.

AU - Tripon, Florin

AU - Dima, Delia

AU - Popov, Viola M.

AU - Vesa, Ștefan C.

AU - Andreescu, Mihaela

AU - Török-Vistai, Tünde

AU - Mihăilă, Romeo G.

AU - Berbec, Nicoleta

AU - Macarie, Ioan

AU - Coliţă, Andrei

AU - Iordache, Maria

AU - Cătană, Alina C.

AU - Farcaș, Marius F.

AU - Tomuleasa, Ciprian

AU - Vasile, Kinga

AU - Truică, Cristina

AU - Todincă, Adriana

AU - Pop-Muntean, Lavinia

AU - Manolache, Raluca

AU - Bumbea, Horia

AU - Vlădăreanu, Ana Maria

AU - Gaman, Mihaela

AU - Ciufu, Cristina M.

AU - Popp, Radu A.

PY - 2018/1

Y1 - 2018/1

N2 - Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical myeloproliferative neoplasms (MPN), characterized by specific somatic mutations in JAK2, CALR or MPL genes. JAK2 46/1 and TERT rs2736100 polymorphisms are known to significantly predispose to MPN. This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN. These three polymorphisms, along with JAK2 46/1 and TERT rs2736100 were genotyped in 939 MPN patients (454 with ET, 337 with PV and 148 with PMF) and 483 controls. MECOM rs2201862 associated significantly with each MPN entity, except for ET, and with all major molecular sub-types, especially those CALR-mutated (OR = 1.4; 95% CI = 1.1-1.8; P-value =.005). HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95% CI = 1.1-1.7; P-value =.003). THRB-RARB rs4858647 had a weak association with PMF only (OR = 1.5; 95% CI = 1-2.1; P-value =.04). Surprisingly, JAK2 46/1 haplotype was associated significantly not only with JAK2 V617F-mutated MPN, but also with CALR-mutated MPN (OR = 1.4; 95% CI = 1.1-1.8; P-value =.01). TERT rs2736100 was associated equally strong with all MPN, regardless of phenotype or molecular sub-type. In conclusion, JAK2 46/1, TERT rs2736100 and MECOM rs2201862 are the chief predisposing polymorphisms to MPN.

AB - Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical myeloproliferative neoplasms (MPN), characterized by specific somatic mutations in JAK2, CALR or MPL genes. JAK2 46/1 and TERT rs2736100 polymorphisms are known to significantly predispose to MPN. This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN. These three polymorphisms, along with JAK2 46/1 and TERT rs2736100 were genotyped in 939 MPN patients (454 with ET, 337 with PV and 148 with PMF) and 483 controls. MECOM rs2201862 associated significantly with each MPN entity, except for ET, and with all major molecular sub-types, especially those CALR-mutated (OR = 1.4; 95% CI = 1.1-1.8; P-value =.005). HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95% CI = 1.1-1.7; P-value =.003). THRB-RARB rs4858647 had a weak association with PMF only (OR = 1.5; 95% CI = 1-2.1; P-value =.04). Surprisingly, JAK2 46/1 haplotype was associated significantly not only with JAK2 V617F-mutated MPN, but also with CALR-mutated MPN (OR = 1.4; 95% CI = 1.1-1.8; P-value =.01). TERT rs2736100 was associated equally strong with all MPN, regardless of phenotype or molecular sub-type. In conclusion, JAK2 46/1, TERT rs2736100 and MECOM rs2201862 are the chief predisposing polymorphisms to MPN.

UR - http://www.scopus.com/inward/record.url?scp=85037706456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037706456&partnerID=8YFLogxK

U2 - 10.1002/ajh.24946

DO - 10.1002/ajh.24946

M3 - Article

C2 - 29047144

AN - SCOPUS:85037706456

VL - 93

SP - 100

EP - 106

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -